Ibere Pharmaceuticals Other Current Liabilities

Ibere Pharmaceuticals (IBER) currently reports a other current liabilities of $310K as of September 2022. That compares with $290K in the prior-year period — up 6.8% year over year. Use the charts on this page to explore Ibere Pharmaceuticals's other current liabilities history and peer comparisons.

Ibere Pharmaceuticals's other current liabilities increased from $290K to $310K — a 6.8% year-over-year increase (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ibere Pharmaceuticals reported $310K in other current liabilities as of September 2022. That compares with $290K in the prior-year period — up 6.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $310K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ibere Pharmaceuticals, and consider following IBER for alerts when major investors trade the stock.